Fingerprint
Dive into the research topics of 'A Phase 2 Multi-institutional Study of Nivolumab for Patients with Advanced Refractory Biliary Tract Cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
A Phase 2 Multi-institutional Study of Nivolumab for Patients with Advanced Refractory Biliary Tract Cancer
Richard D. Kim, Vincent Chung, Olatunji B. Alese, Bassell F. El-Rayes, Daneng Li, Taymeyah E. Al-Toubah, Michael J. Schell, Jun Min Zhou, Amit Mahipal, Baek Hui Kim, Dae Won Kim
Research output: Contribution to journal › Article › peer-review
41
Scopus
citations